Stocks News

LAST PRICE
10.3100
TODAY'S CHANGE (%)
Trending Down-0.6900 (-6.2727%)

Bid / Lots
10.3000/ 1
Ask / Lots
10.3100/ 2
Open / Previous Close
10.8300 / 11.0000
Day Range
Low 10.1600
High 10.9500
52 Week Range
Low 2.5700
High 13.8500
Volume
924,689
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 4, 2024
- CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
  8:30AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: CRMD
  
  CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
  
  BERKELEY HEIGHTS, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that management will be participating in the Truist Securities BioPharma Symposium, taking place in New York City on Thursday, November 7, 2024.
Oct 31, 2024
- DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
  6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: CRMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 06:21 ET (10:21 GMT)
Oct 30, 2024
- DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
  11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: CRMD
  
  CorMedix Inc. ( CRMD ) is currently at $10.93, down $2.04 or 15.73%
  
  --Would be lowest close since Oct. 17, 2024, when it closed at $10.49
  
  --On pace for largest percent decrease since June 29, 2023, when it fell 22.29%
- -- Earnings Flash (CRMD) CORMEDIX Posts Q3 Revenue $11.5M, from 7:32AM ET on Wednesday Oct 30, 2024 by MT Newswires
  7:32AM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: CRMD
  07:32 AM EDT, 10/30/2024 (MT Newswires) -- ...
- *DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: CRMD

Yesterday
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information, from 23 hours ago by Newsfile
  23 hours ago by Newsfile
  Companies Mentioned: ELTP
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information, from 23 hours ago by Dow Jones
  23 hours ago by Dow Jones
  Companies Mentioned: ELTP
- DJ Zevra Therapeutics Is Maintained at Buy by Canaccord Genuity, from 11:27AM ET on Thursday Nov 14, 2024 by Dow Jones
  11:27AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ZVRA
Nov 13, 2024
- DJ Eton Pharmaceuticals Price Target Maintained With a $11.00/Share by HC Wainwright & Co., from 8:58AM ET on Wednesday Nov 13, 2024 by Dow Jones
  8:58AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: ETON
Nov 12, 2024
- *DJ Zevra Therapeutics 3Q Rev $3.7M >ZVRA, from 5:39PM ET on Tuesday Nov 12, 2024 by Dow Jones
  5:39PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ZVRA
- -- Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q3 Revenue $3.7M, from 4:20PM ET on Tuesday Nov 12, 2024 by MT Newswires
  4:20PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: ZVRA
- -- Earnings Flash (ETON) ETON PHARMACEUTICALS Reports Q3 Revenue $10.3M, from 4:05PM ET on Tuesday Nov 12, 2024 by MT Newswires
  4:05PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: ETON
- Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ZVRA
- *DJ Eton Pharmaceuticals 3Q EPS 2c >ETON, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ETON
- Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ETON

CorMedix Inc
NASDAQ:CRMDUnited States

Search Criteria

Nov 4, 2024

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones

Oct 31, 2024

DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 30, 2024

DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones

-- Earnings Flash (CRMD) CORMEDIX Posts Q3 Revenue $11.5M, from 7:32AM ET on Wednesday Oct 30, 2024 by MT Newswires

*DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

Peers Headlines

Yesterday

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information, from 23 hours ago by Newsfile

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information, from 23 hours ago by Dow Jones

DJ Zevra Therapeutics Is Maintained at Buy by Canaccord Genuity, from 11:27AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

DJ Eton Pharmaceuticals Price Target Maintained With a $11.00/Share by HC Wainwright & Co., from 8:58AM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

*DJ Zevra Therapeutics 3Q Rev $3.7M >ZVRA, from 5:39PM ET on Tuesday Nov 12, 2024 by Dow Jones

-- Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q3 Revenue $3.7M, from 4:20PM ET on Tuesday Nov 12, 2024 by MT Newswires

-- Earnings Flash (ETON) ETON PHARMACEUTICALS Reports Q3 Revenue $10.3M, from 4:05PM ET on Tuesday Nov 12, 2024 by MT Newswires

Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones

*DJ Eton Pharmaceuticals 3Q EPS 2c >ETON, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones